{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T13:29:21Z","timestamp":1791725361360,"version":"4.3.4"},"reference-count":22,"publisher":"Elsevier BV","issue":"2","content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Antiviral Research"],"published-print":{"date-parts":[[2013,8]]},"DOI":"10.1016\/j.antiviral.2013.05.008","type":"journal-article","created":{"date-parts":[[2013,5,27]],"date-time":"2013-05-27T06:02:47Z","timestamp":1369634567000},"page":"136-138","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":58,"title":["Association of single nucleotide polymorphism rs3775291 in the coding region of the TLR3 gene with predisposition to tick-borne encephalitis in a Russian population"],"prefix":"10.1016","volume":"99","author":[{"given":"Andrey V.","family":"Barkhash","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mikhail I.","family":"Voevoda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aida G.","family":"Romaschenko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.antiviral.2013.05.008_b0005","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1086\/657418","article-title":"Variability in the 2\u2032-5\u2032-oligoadenylate synthetase gene cluster is associated with human predisposition to tick-borne encephalitis virus-induced disease","volume":"202","author":"Barkhash","year":"2010","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.antiviral.2013.05.008_b0010","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.antiviral.2011.10.017","article-title":"Single nucleotide polymorphism in the promoter region of the CD209 gene is associated with human predisposition to severe forms of tick-borne encephalitis","volume":"93","author":"Barkhash","year":"2012","journal-title":"Antiviral Res."},{"key":"10.1016\/j.antiviral.2013.05.008_b0015","doi-asserted-by":"crossref","first-page":"10349","DOI":"10.1128\/JVI.00935-08","article-title":"Toll-like receptor 3 has a protective role against West Nile virus infection","volume":"82","author":"Daffis","year":"2008","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2013.05.008_b0020","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1084\/jem.20042530","article-title":"Chemokine receptor CCR5 promotes leukocyte trafficking to the brain and survival in West Nile virus infection","volume":"202","author":"Glass","year":"2005","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.antiviral.2013.05.008_b0025","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1084\/jem.20051970","article-title":"CCR5 deficiency increases risk of symptomatic West Nile virus infection","volume":"203","author":"Glass","year":"2006","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.antiviral.2013.05.008_b0030","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S0166-3542(02)00206-1","article-title":"Tick-borne encephalitis","volume":"57","author":"Gritsun","year":"2003","journal-title":"Antiviral Res."},{"key":"10.1016\/j.antiviral.2013.05.008_b0035","series-title":"Tick-borne encephalitis. Manual for physicians","author":"Ierusalimsky","year":"2001"},{"key":"10.1016\/j.antiviral.2013.05.008_b0040","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1086\/524709","article-title":"A deletion in the chemokine receptor 5 (CCR5) gene is associated with tickborne encephalitis","volume":"197","author":"Kindberg","year":"2008","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.antiviral.2013.05.008_b0045","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1093\/infdis\/jiq082","article-title":"A functional Toll-like receptor 3 gene (TLR3) may be a risk factor for tick-borne encephalitis virus (TBEV) infection","volume":"203","author":"Kindberg","year":"2011","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.antiviral.2013.05.008_b0050","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/j.bbrc.2009.08.062","article-title":"Toll-like receptors and innate immunity","volume":"388","author":"Kumar","year":"2009","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.antiviral.2013.05.008_b0055","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1086\/524691","article-title":"Genetic deficiency of chemokine receptor CCR5 is a strong risk factor for symptomatic West Nile virus infection: a meta-analysis of 4 cohorts in the US epidemic","volume":"197","author":"Lim","year":"2008","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.antiviral.2013.05.008_b0060","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1086\/649426","article-title":"CCR5 deficiency is a risk factor for early clinical manifestations of West Nile virus infection but not for viral transmission","volume":"2010","author":"Lim","year":"2010","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.antiviral.2013.05.008_b0065","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1002\/rmv.680","article-title":"Antiviral responses induced by the TLR3 pathway","volume":"21","author":"Matsumoto","year":"2011","journal-title":"Rev. Med. Virol."},{"key":"10.1016\/j.antiviral.2013.05.008_b0070","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/S0168-9525(02)02820-2","article-title":"Web-based primer design for single nucleotide polymorphism analysis","volume":"18","author":"Neff","year":"2002","journal-title":"Trends Genet."},{"key":"10.1016\/j.antiviral.2013.05.008_b0075","doi-asserted-by":"crossref","first-page":"17696","DOI":"10.1074\/jbc.M700209200","article-title":"Effects of single nucleotide polymorphisms on Toll-like receptor 3 activity and expression in cultured cells","volume":"282","author":"Ranjith-Kumar","year":"2007","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.antiviral.2013.05.008_b0080","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.tmaid.2010.06.004","article-title":"Tick-borne encephalitis: pathogenesis and clinical implications","volume":"8","author":"Ruzek","year":"2010","journal-title":"Travel Med. Infect. Dis."},{"key":"10.1016\/j.antiviral.2013.05.008_b0085","series-title":"Molecular Cloning: A Laboratory Manual (second ed.)","author":"Sambrook","year":"1989"},{"key":"10.1016\/j.antiviral.2013.05.008_b0090","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2807\/ese.13.26.18916-en","article-title":"Tick-borne encephalitis in Europe and beyond \u2013 the epidemiological situation as of 2007","volume":"13","author":"Suss","year":"2008","journal-title":"Eurosurveillance"},{"key":"10.1016\/j.antiviral.2013.05.008_b0095","article-title":"Tick-borne encephalitis is regional problem","volume":"8","author":"Tolokonskaya","year":"2007","journal-title":"Siberian Council"},{"key":"10.1016\/j.antiviral.2013.05.008_b0100","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1093\/qjmed\/hcs013","article-title":"Encephalitis caused by flaviviruses","volume":"105","author":"Turtle","year":"2012","journal-title":"QJM"},{"key":"10.1016\/j.antiviral.2013.05.008_b0105","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1038\/nm1140","article-title":"Toll-like receptor 3 mediates West Nile virus entry into the brain causing lethal encephalitis","volume":"10","author":"Wang","year":"2004","journal-title":"Nat. Med."},{"key":"10.1016\/j.antiviral.2013.05.008_b0110","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1093\/oxfordjournals.jhered.a111304","article-title":"Two programs to estimate significance of \u03c72 values using pseudo-probability tests","volume":"84","author":"Zaykin","year":"1993","journal-title":"J. Hered."}],"container-title":["Antiviral Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354213001393?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354213001393?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,2,22]],"date-time":"2022-02-22T22:52:57Z","timestamp":1645570377000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166354213001393"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,8]]},"references-count":22,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2013,8]]}},"alternative-id":["S0166354213001393"],"URL":"https:\/\/doi.org\/10.1016\/j.antiviral.2013.05.008","relation":{},"ISSN":["0166-3542"],"issn-type":[{"value":"0166-3542","type":"print"}],"subject":[],"published":{"date-parts":[[2013,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Association of single nucleotide polymorphism rs3775291 in the coding region of the TLR3 gene with predisposition to tick-borne encephalitis in a Russian population","name":"articletitle","label":"Article Title"},{"value":"Antiviral Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.antiviral.2013.05.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}